Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

US FDA Approves Eton's Liquid Therapy for Rare Water-balance Disorder

The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a ⁠rare hormonal disorder, offering a more precise...

Nearly a Third of US Youth Have Prediabetes or Diabetes

Nearly 1 in 3 US adolescents have prediabetes or type 2 diabetes, with abdominal adiposity being the strongest independent predictor, analysis of national survey data from 2021 to 2023 shows.

Gut Flora May Be Altered by Oral Semaglutide Additive

Salcaprozate sodium, the absorption-enhancing ingredient used in oral semaglutide, is associated with changes in gut microbiota and inflammatory markers in a preclinical study.

ChatGPT Excels at Classifying Ultraprocessed Foods

ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve future dietary research.

GPs ‘Reeling’ Over New Contract in England

A new GP contract for England promises same-day urgent appointments, but medical leaders warn it raises unrealistic expectations and workload risks.

Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.

Todays Updates

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Todays Updates

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Latest News

The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a ⁠rare hormonal disorder, offering a more precise...

Nearly 1 in 3 US adolescents have prediabetes or type 2 diabetes, with abdominal adiposity being the strongest independent predictor, analysis of national survey data from 2021 to 2023 shows.

Salcaprozate sodium, the absorption-enhancing ingredient used in oral semaglutide, is associated with changes in gut microbiota and inflammatory markers in a preclinical study.

ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve future dietary research.

A new GP contract for England promises same-day urgent appointments, but medical leaders warn it raises unrealistic expectations and workload risks.

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.

News All Time

Intermittent Fasting Offers No Clear Advantage

Analysis of 22 randomized trials finds intermittent fasting produces modest weight loss comparable to standard calorie-restricted diets and shows no clear quality-of-life benefit.

When Heavy or Light Periods Signal Reproductive Risk

Heavy or scant menses often reflect ovulatory, uterine, or hormonal disorders that can indirectly impair conception; targeted evaluation identifies treatable causes to protect fertility.

Novo Nordisk's CagriSema Trial Deals Blow in Obesity Drug Battle With Eli Lilly

Novo Nordisk's next-generation obesity drug CagriSema underperformed Eli Lilly's Zepbound in a head-to-head trial, the Danish drugmaker said on Monday, as it suffered a...

SGA Children on Growth Hormone Show Impaired Metabolism

Children born small for gestational age vs those with isolated growth hormone deficiency have impaired glucose-insulin metabolism, which worsens during growth hormone therapy.

Chan Zuckerberg Initiative Bets on Human Cell Atlas

Backed by multibillion-dollar funding, the initiative scales computing power and cell mapping to accelerate therapy discovery and immune system modelling.

Tirzepatide Now Available in Multi-Dose KwikPen

Patients who pay cash can get the multi-dose KwikPen device on LillyDirect, with prices starting at $299 for the lowest dose.

PFAS Exposure Linked to Higher Gestational Diabetes Risk

The largest meta-analysis yet conducted on the topic suggests that PFAS “forever chemicals” increase the risk for gestational diabetes, highlighting the need for exposure reduction and patient counseling.

Supportive vs Flat Flexible Shoes: No Hip OA Pain Difference

The use of stable supportive shoes does not reduce 6‑month walking hip pain in adults with chronic hip osteoarthritis more than the use of flat flexible ones, according to a randomized clinical trial.

Federal Health Data is Back Online, But Docs Still Skeptical

Information has been restored after the federal government took health information and data websites offline last year - but some physicians say their trust is shaken.

New Intervention Bests Cutting Calories for Weight Loss

Women with obesity can lose more weight with a novel multicomponent nutrition intervention called NutrirCom than on a calorie-restricted diet.

Energy Deficit and Bone Loss in Female Athletes

Social media may glamorize athletes’ diets, but restrictive eating combined with intense training can produce low energy availability, menstrual dysfunction, and bone loss in female competitors.

Why Obesity Research Is Far From Over

Clinicians warn that GLP-1 treatment often ends within a year and can lead to rapid weight regain; experts urge personalized nutrition, behavioral care, and continued research.

Digital Coaching Can Help Control Blood Glucose in T2D

A diabetes management system with personalized remote coaching can improve glycemic control to a greater extent than usual care in patients with T2D.

What Nutrients Are GLP-1 Users Lacking?

In adults with obesity and/or type 2 diabetes, GLP-1 therapy may lead to nutritional imbalances, with growing evidence indicating depletion of vitamin D, iron, and the B vitamin complex.

Gallbladder Removal Alters Resting Fat Metabolism

Cholecystectomy is associated with increased sleep energy expenditure, higher lipid oxidation, and a lower respiratory exchange ratio in Indigenous American adults.